US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist
  • 1.140
  • -0.030-2.56%
Close Dec 3 16:00 ET
  • 1.140
  • 0.0000.00%
Post 20:01 ET
72.22MMarket Cap-1252P/E (TTM)

Cue Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.49%-7.53M
3.67%-9.99M
9.68%-9.78M
4.41%-39.96M
-4.22%-10.96M
-13.51%-7.8M
19.28%-10.37M
6.39%-10.83M
-7.64%-41.81M
1.23%-10.51M
Net income from continuing operations
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
4.30%-50.73M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.04%-14.59M
Operating gains losses
---98K
----
----
3,825.00%157K
-38.37%159K
--0
--0
---2K
118.56%4K
47,009.09%258K
Depreciation and amortization
2.45%877K
1.53%862K
-3.52%849K
90.25%3.44M
46.72%851K
58.81%856K
85.37%849K
284.28%880K
201.58%1.81M
109.46%580K
Other non cash items
0.00%43K
0.00%41K
0.00%42K
221.90%167K
117.52%41K
2.38%43K
-21.15%41K
1,300.00%42K
---137K
---234K
Change In working capital
-617.07%-1.27M
-6,095.00%-2.48M
44.42%-274K
-362.36%-934K
-140.90%-647K
-84.03%246K
98.19%-40K
12.12%-493K
108.11%356K
76.65%1.58M
-Change in receivables
-148.10%-1.31M
52.35%-447K
314.39%298K
-153.19%-1.64M
-105.15%-38K
-776.67%-526K
-596.30%-938K
-106.27%-139K
278.84%3.09M
131.13%738K
-Change in prepaid assets
-54.42%340K
-51.79%216K
27.63%-998K
106.93%25K
-76.14%210K
-32.30%746K
134.38%448K
-32.60%-1.38M
-81.45%-361K
23.07%880K
-Change in payables and accrued expense
1.86%1.2M
-145.85%-658K
215.52%1.49M
237.45%1.36M
-89.74%31K
48.55%1.18M
260.16%1.44M
-8.41%-1.29M
-141.99%-988K
-59.79%302K
-Change in other current liabilities
-11.69%-793K
-10.40%-775K
-13.65%-741K
-279.32%-2.79M
-114.20%-724K
-139.06%-710K
-260.00%-702K
-786.32%-652K
-125.29%-735K
-105.27%-338K
-Change in other working capital
-61.12%-717K
-187.63%-814K
-110.86%-322K
427.44%2.11M
---126K
---445K
---283K
559.84%2.97M
91.91%-645K
--0
Cash from discontinued investing activities
Operating cash flow
3.49%-7.53M
3.67%-9.99M
9.68%-9.78M
4.41%-39.96M
-4.22%-10.96M
-13.51%-7.8M
19.28%-10.37M
6.39%-10.83M
-7.64%-41.81M
1.23%-10.51M
Investing cash flow
Cash flow from continuing investing activities
-98.04%98K
-100.20%-10K
-100.37%-55K
201.59%25M
0
116.94%5M
8,164.52%5M
55,662.96%15M
-370.19%-24.61M
978,177.89%5M
Net PPE purchase and sale
--98K
---10K
-2,850.00%-55K
101.21%2K
--0
--0
--0
107.41%2K
81.49%-165K
-295.69%-1K
Net investment purchase and sale
--0
--0
--0
202.27%25M
--0
116.98%5M
--5M
--15M
-344.45%-24.45M
--5M
Cash from discontinued investing activities
Investing cash flow
-98.04%98K
-100.20%-10K
-100.37%-55K
201.59%25M
--0
116.94%5M
8,164.52%5M
55,662.96%15M
-370.19%-24.61M
978,177.89%5M
Financing cash flow
Cash flow from continuing financing activities
114.01%9.82M
-147.60%-1M
506.70%2.35M
-77.90%11.86M
-82.55%4.78M
51,088.89%4.59M
-81.09%2.1M
-97.44%388K
178.99%53.66M
271.20%27.4M
Net issuance payments of debt
0.00%-1M
---1M
---1M
-120.00%-2M
---1M
---1M
--0
--0
--10M
--0
Net common stock issuance
93.61%10.82M
--0
--3.35M
-65.94%13.39M
-74.53%5.78M
--5.59M
-81.85%2.02M
--0
126.06%39.3M
223.04%22.7M
Proceeds from stock option exercised by employees
--0
--0
--0
-89.94%473K
--0
--0
--85K
--388K
80.85%4.7M
773.96%4.7M
Net other financing activities
----
----
----
----
----
----
----
----
54.54%-341K
100.55%1K
Cash from discontinued financing activities
Financing cash flow
114.01%9.82M
-147.60%-1M
506.70%2.35M
-77.90%11.86M
-82.55%4.78M
51,088.89%4.59M
-81.09%2.1M
-97.44%388K
178.99%53.66M
271.20%27.4M
Net cash flow
Beginning cash position
-43.11%30.18M
-26.88%41.18M
-5.99%48.67M
-19.77%51.76M
83.56%54.84M
-19.95%53.05M
-17.27%56.32M
-19.77%51.76M
-13.99%64.52M
-55.92%29.88M
Current changes in cash
33.63%2.39M
-236.39%-11M
-264.25%-7.49M
75.71%-3.1M
-128.22%-6.18M
104.92%1.79M
-81.57%-3.27M
28.15%4.56M
-21.55%-12.76M
770.93%21.89M
End cash Position
-40.61%32.57M
-43.11%30.18M
-26.88%41.18M
-5.99%48.67M
-5.99%48.67M
83.56%54.84M
-19.95%53.05M
-17.27%56.32M
-19.77%51.76M
-19.77%51.76M
Free cash flow
3.50%-7.53M
3.58%-10M
9.18%-9.84M
4.80%-39.96M
-4.21%-10.96M
-12.23%-7.8M
19.69%-10.37M
6.61%-10.83M
-5.60%-41.98M
1.22%-10.52M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.49%-7.53M3.67%-9.99M9.68%-9.78M4.41%-39.96M-4.22%-10.96M-13.51%-7.8M19.28%-10.37M6.39%-10.83M-7.64%-41.81M1.23%-10.51M
Net income from continuing operations 21.31%-8.66M22.86%-10.17M5.81%-12.35M4.30%-50.73M7.94%-13.43M-0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.04%-14.59M
Operating gains losses ---98K--------3,825.00%157K-38.37%159K--0--0---2K118.56%4K47,009.09%258K
Depreciation and amortization 2.45%877K1.53%862K-3.52%849K90.25%3.44M46.72%851K58.81%856K85.37%849K284.28%880K201.58%1.81M109.46%580K
Other non cash items 0.00%43K0.00%41K0.00%42K221.90%167K117.52%41K2.38%43K-21.15%41K1,300.00%42K---137K---234K
Change In working capital -617.07%-1.27M-6,095.00%-2.48M44.42%-274K-362.36%-934K-140.90%-647K-84.03%246K98.19%-40K12.12%-493K108.11%356K76.65%1.58M
-Change in receivables -148.10%-1.31M52.35%-447K314.39%298K-153.19%-1.64M-105.15%-38K-776.67%-526K-596.30%-938K-106.27%-139K278.84%3.09M131.13%738K
-Change in prepaid assets -54.42%340K-51.79%216K27.63%-998K106.93%25K-76.14%210K-32.30%746K134.38%448K-32.60%-1.38M-81.45%-361K23.07%880K
-Change in payables and accrued expense 1.86%1.2M-145.85%-658K215.52%1.49M237.45%1.36M-89.74%31K48.55%1.18M260.16%1.44M-8.41%-1.29M-141.99%-988K-59.79%302K
-Change in other current liabilities -11.69%-793K-10.40%-775K-13.65%-741K-279.32%-2.79M-114.20%-724K-139.06%-710K-260.00%-702K-786.32%-652K-125.29%-735K-105.27%-338K
-Change in other working capital -61.12%-717K-187.63%-814K-110.86%-322K427.44%2.11M---126K---445K---283K559.84%2.97M91.91%-645K--0
Cash from discontinued investing activities
Operating cash flow 3.49%-7.53M3.67%-9.99M9.68%-9.78M4.41%-39.96M-4.22%-10.96M-13.51%-7.8M19.28%-10.37M6.39%-10.83M-7.64%-41.81M1.23%-10.51M
Investing cash flow
Cash flow from continuing investing activities -98.04%98K-100.20%-10K-100.37%-55K201.59%25M0116.94%5M8,164.52%5M55,662.96%15M-370.19%-24.61M978,177.89%5M
Net PPE purchase and sale --98K---10K-2,850.00%-55K101.21%2K--0--0--0107.41%2K81.49%-165K-295.69%-1K
Net investment purchase and sale --0--0--0202.27%25M--0116.98%5M--5M--15M-344.45%-24.45M--5M
Cash from discontinued investing activities
Investing cash flow -98.04%98K-100.20%-10K-100.37%-55K201.59%25M--0116.94%5M8,164.52%5M55,662.96%15M-370.19%-24.61M978,177.89%5M
Financing cash flow
Cash flow from continuing financing activities 114.01%9.82M-147.60%-1M506.70%2.35M-77.90%11.86M-82.55%4.78M51,088.89%4.59M-81.09%2.1M-97.44%388K178.99%53.66M271.20%27.4M
Net issuance payments of debt 0.00%-1M---1M---1M-120.00%-2M---1M---1M--0--0--10M--0
Net common stock issuance 93.61%10.82M--0--3.35M-65.94%13.39M-74.53%5.78M--5.59M-81.85%2.02M--0126.06%39.3M223.04%22.7M
Proceeds from stock option exercised by employees --0--0--0-89.94%473K--0--0--85K--388K80.85%4.7M773.96%4.7M
Net other financing activities --------------------------------54.54%-341K100.55%1K
Cash from discontinued financing activities
Financing cash flow 114.01%9.82M-147.60%-1M506.70%2.35M-77.90%11.86M-82.55%4.78M51,088.89%4.59M-81.09%2.1M-97.44%388K178.99%53.66M271.20%27.4M
Net cash flow
Beginning cash position -43.11%30.18M-26.88%41.18M-5.99%48.67M-19.77%51.76M83.56%54.84M-19.95%53.05M-17.27%56.32M-19.77%51.76M-13.99%64.52M-55.92%29.88M
Current changes in cash 33.63%2.39M-236.39%-11M-264.25%-7.49M75.71%-3.1M-128.22%-6.18M104.92%1.79M-81.57%-3.27M28.15%4.56M-21.55%-12.76M770.93%21.89M
End cash Position -40.61%32.57M-43.11%30.18M-26.88%41.18M-5.99%48.67M-5.99%48.67M83.56%54.84M-19.95%53.05M-17.27%56.32M-19.77%51.76M-19.77%51.76M
Free cash flow 3.50%-7.53M3.58%-10M9.18%-9.84M4.80%-39.96M-4.21%-10.96M-12.23%-7.8M19.69%-10.37M6.61%-10.83M-5.60%-41.98M1.22%-10.52M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Meta Platforms
META
+3.51%
Taiwan Semiconductor
TSM
+2.31%
Amazon
AMZN
+1.30%
Apple
AAPL
+1.28%
NVIDIA
NVDA
+1.18%

Unlock the Full List